Therapeutic Targeting of Fibrotic Epithelial-Mesenchymal Transition–An Outstanding Challenge
نویسندگان
چکیده
منابع مشابه
Can a fibrotic liver afford epithelial-mesenchymal transition?
The question whether epithelial-mesenchymal transition (EMT) occurs during liver fibrogenesis is a controversial issue. In vitro studies confirm that hepatocytes or cholangiocytes undergo EMT upon transforming growth factor β (TGF-β) stimulation, whereas in vivo experiments based on genetic fate mapping of specific cell populations suggest that EMT does not occur in fibrotic animal models. In t...
متن کاملInvolvement of renal progenitor tubular cells in epithelial-to-mesenchymal transition in fibrotic rat kidneys.
Renal progenitor tubular cells (label-retaining cells [LRC]) were recently identified in normal kidneys by in vivo bromodeoxyuridine (BrdU) labeling. This study was conducted to examine the behavior of LRC in renal fibrosis. BrdU was injected intraperitoneally into normal rats daily for 7 d. After a 2-wk chase period, unilateral ureteral obstruction (UUO) was induced in these rats. In normal an...
متن کاملTargeting the tricuspid valve: A new therapeutic challenge.
a Department of Cardiology, Heart Valve Clinic, University of Liège Hospital, University Hospital, GIGA Cardiovascular Sciences, CHU du Sart Tilman, 1, avenue de l’Hôpital, 4000 Liège, Belgium b Gruppo Villa Maria Care and Research, E.S. Health Science Foundation, Lugo (RA), Italy c Department of Cardiovascular Surgery, GVM Care and Research, Maria Eleonora Hospital, Department of Surgery and C...
متن کاملTargeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.
Metastasis is responsible for 90% of cancer-related deaths. Strategies are needed that can inhibit the capacity of cancer cells to migrate across the anatomic barriers and colonize distant organs. Here, we show an association between metastasis and expression of a type I receptor tyrosine kinase-like orphan receptor, ROR1, which is expressed during embryogenesis and by various cancers, but not ...
متن کاملNovel clinical therapeutics targeting the epithelial to mesenchymal transition
The epithelial to mesenchymal transition (EMT) is implicated in many processes, ranging from tissue and organogenesis to cancer and metastatic spread. Understanding the key regulatory mechanisms and mediators within this process offers the opportunity to develop novel therapeutics with broad clinical applicability. To date, several components of EMT already are targeted using pharmacologic agen...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Pharmacology
سال: 2019
ISSN: 1663-9812
DOI: 10.3389/fphar.2019.00388